ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories Financial Stability

Announcement as on 07 July 2025

Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment
Dr. Reddy's Laboratories has partnered with Alvotech to co-develop and commercialize a biosimilar for pembrolizumab (Keytruda), a crucial cancer treatment with USD 29.5 billion in 2024 sales. The collaboration aims to expedite development and broaden globa
Announcement as on 05 June 2025

Dr Reddy’s, Alvotech to co-develop Keytruda biosimilar
Dr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a highly successful cancer drug. This partnership aims to provide more affordable treatment options globally as Merck's pat
Announcement as on 05 June 2025

Dr Reddy's gets 2 observations from USFDA for Telangana API plant
Dr. Reddy's Laboratories received a Form 483 with two observations following a GMP inspection by the USFDA at its API manufacturing plant (CTO-5) in Miryalaguda, Telangana. The inspection, conducted from May 19 to May 24, 2025, identified potential violati
Announcement as on 25 May 2025

Dr Reddy's gets 2 observations from USFDA for New York API plant
Dr. Reddy's Laboratories announced that the USFDA issued a Form 483 with two observations after a GMP inspection of its API manufacturing facility in Middleburgh, New York. The inspection, conducted between May 12-16, 2025, identified potential violations
Announcement as on 17 May 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.17
  • 12Day Average: 12.17
  • 20Day Average: 12.21
  • 50Day Average: 12.72
  • 100Day Average: 13.06
  • 150Day Average: 13.37
  • 200Day Average: 13.48

RDY Indicators & signals

Indicator MACD (12,26,9)

12.19, 12.26, -0.11
Indicator MACD is in negative zone

Indicator ADX (14)

0, 31.82, 31.82
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Tue Sep 2026 12.17 12.15 to 12.28 0.33% 0.89 times
31 Mon Aug 2026 12.13 12.01 to 12.22 -0.41% 0.99 times
28 Fri Aug 2026 12.18 12.12 to 12.33 0.16% 0.77 times
27 Thu Aug 2026 12.16 12.13 to 12.24 -0.49% 0.71 times
26 Wed Aug 2026 12.22 12.14 to 12.30 -0.97% 0.77 times
25 Tue Aug 2026 12.34 12.22 to 12.38 0.98% 0.81 times
24 Mon Aug 2026 12.22 12.13 to 12.25 0.33% 0.95 times
21 Fri Aug 2026 12.18 12.07 to 12.23 0.58% 0.93 times
20 Thu Aug 2026 12.11 12.05 to 12.23 0% 1.17 times
19 Wed Aug 2026 12.11 11.99 to 12.22 -0.33% 1.5 times
18 Tue Aug 2026 12.15 12.06 to 12.21 0.33% 1.41 times
17 Mon Aug 2026 12.11 12.06 to 12.24 -1.3% 0.94 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top